Document ID: chunk:federal_register_of_legislation:F2024C01255:body:0:p9
Version: federal_register_of_legislation:F2024C01255
Segment Type: other
Provision Reference: 
Character Range: 22730–25807

the Register, the name of the pharmaceutical form of the medicine;

       name of the medicine means the following:
           (a) where the medicine is intended to be, or is, entered in the Register - the name of the medicine intended to appear or appearing on the Certificate of Registration in relation to the medicine, not including the following information:
               1.             the name of the active ingredient (except where the name of the active ingredient is intended by the sponsor to be, or because of the way it is represented, to form part of the name of the medicine);
               2.          the strength (except where numbers or words denoting strength are included in that name to differentiate medicines, by strength);
               3.        the dosage form (except where this is integral to differentiate medicines from other medicines);
               4.         container details;
               5.           the pack size;
               6.         'new formulation' or representations to the same effect;

               7.      flavour descriptors (except where this is integral to differentiate medicines from other medicines);
               8.     the name of the sponsor or distributor (or part thereof) (except where the name is intended by the sponsor to be, or because of the way it is represented, to form part of the name of the medicine); and
            1.           where the medicine is neither intended to be, nor is, entered in the Register:
           1.         the registered trade mark for the medicine; or
               2.           a unique, invented, common or scientific name
           assigned to the medicine by the sponsor and appearing on the label;

       neuromuscular blocking agent means, for the purposes of this Order, any of the ingredients (or salts thereof) specified in Schedule 3 to this Order;

       osmolality means the number of osmoles (usually expressed as milliosmoles or mOsm) of the solute in a kilogram of water;

       pharmaceutical benefit has the same meaning as in the Regulations;

       Poisons Standard means the current Poisons Standard as defined in section 52A of the Act;

       primary pack has the same meaning as in the Act;

       quantity of the medicine means:
           (a) where the medicine consists of discrete dosage units, such as tablets or capsules – the stated number of units in the container; or
           (b) where the medicine is:
              (i) a solid or semi-solid, other than a biological medicine or a medicine for injection - the stated weight in the container;
              (ii) a liquid, other than a biological medicine - the stated volume of fill in the container;
              (iii) a pressurised metered-dose preparation or dry powder inhaler - the stated number of deliverable doses in the container;
              (iv) a non-pressurised metered dose preparation - the minimum number of deliverable doses in the container;
              (v) a solid biological medicine - the stated weight, number of doses or potency units in the